Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof-of-concept and dose-finding study of BAY 1007626 intrauterine system vs Mirena and Jaydess
2013-003980-74Phase 2Completed
- Sponsor
- Bayer
- Start
- Apr 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of bay-1007626 in contraception and None (3 arms), sponsored by Bayer. Primary endpoints: Primary pharmacodynamic endpoints, Primary pharmacokinetic endpoints and 1 more. Started Apr 2015; status: completed.
02
Drugs
bay-1007626
03
Conditions
contraception
Beyond the preview
Go deeper on 2013-003980-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003980-74.